Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Matthew Scalo - SVP, Investor Relations Paul Diaz - CEO, President & Director Nicole Lambert - COO Bryan Riggsbee - EVP, CFO & Treasurer Conference Call Participants Daniel Brennan - Life Science & Diagnostic Tools Matthew Sykes - Goldman Sachs Jack Meehan - Nephron Research Mason Carrico - Stephens Incorporated Brandon Couillard - Jefferies Julia Kim - JPMorgan Puneet Souda - SVB Securities ...